Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01745536

Closed Vitrification of Oocytes

"Impact of a Closed System in Donor Oocyte Vitrification"

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to evaluate the use of a closed device for storage of vitrified oocytes.

Detailed description

The Cryotop method for oocyte vitrification is classified as "open system", which means that it requires direct contact with liquid nitrogen during the vitrification process. The system has an external straw to protect the samples during storage, but the device is not hermetically sealed. Instead closed systems are devices that are hermetically sealed before vitrification and remain sealed during storage. Open systems have proven highly effective in achieving similar outcomes with vitrified oocytes compared to those achieved with fresh ones. On the contrary, closed systems have failed to be as effective as open ones when used for oocyte vitrification. Although open systems have proven to be highly efficient, where many other methods have failed, they have been related to a theoretical risk of contamination due to direct contact with liquid nitrogen. Though to date there have been no reported cases of transmission of disease after cryo-transfers either for slow freezing or vitrification, some European countries prohibit the use of open systems for vitrification. In this study, we will evaluate the results after the donor oocyte vitrification, using a modification of a current device (Cryotop®), which makes it capable of being hermetically sealed. The current study is a prospective randomized trial aimed to assess the outcome of ovum donation cycles conducted with vitrified oocytes using the closed device versus oocytes vitrified using the traditional open device.

Conditions

Interventions

TypeNameDescription
PROCEDUREOocytes are vitrified/stored using a closed deviceVitrification will be carried out using a modification of the current device (Cryotop®), thus providing air tight sealing. Closed systems are devices that are hermetically sealed before vitrification and remain sealed during storage.
PROCEDUREOocytes are vitrified/stored using an open deviceThe vitrification process takes place through direct contact with liquid nitrogen. The system has an external straw to protect the samples during storage, but the device is not hermetically sealed.

Timeline

Start date
2012-11-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2012-12-10
Last updated
2016-03-08

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01745536. Inclusion in this directory is not an endorsement.